Quality Improvement Study on Human Papilloma Virus (HPV) Vaccination uptake in HIV patients

Files

Authors

Hassan Akram, Oakland University William Beaumont School of Medicine Medical Student
Paul Johnson, Beaumont Health
Trini A Mathew, Beaumont Health

Description

INTRODUCTION HPV is strongly associated with cervical cancer and cancers of vagina, vulva, penis, anus, rectum. In 2019, WHO identified vaccine hesitancy as top 10 global threats and planned to increase the HPV vaccine coverage. In June 2019 Advisory Committee on Immunization Practices (ACIP) in the US recommended shared clinical decision-making regarding HPV vaccinations in adults aged 26 through 45 years. The goal of this project is to evaluate the uptake of HPV vaccination and challenges in the HIV patients at Beaumont Hospital.

Publication Date

5-2-2022

Keywords

HIV, human papilloma virus

Disciplines

Infectious Disease

Recommended Citation

Akram H, Johnson P, Mathew T. Quality improvement study on human papilloma virus (HPV) vaccination uptake in HIV patients. Poster presented at: Oakland University William Beaumont School of Medicine Embark Capstone Colloquium; 2022 May 2; Rochester Hills, MI.

Comments

The Embark Capstone Colloquium at the Oakland University William Beaumont School of Medicine, Rochester Hills, MI, May 2, 2022.